full-year

Piramal Pharma Limited Announces Results for Q4 and Full-year FY26

MUMBAI, India, April 28, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health…

6 days ago

Hikvision releases 2025 full-year and 2026 first-quarter financial results

HANGZHOU, China, April 27, 2026 /PRNewswire/ -- Hikvision has released its full-year 2025 and first-quarter 2026 financial results, demonstrating steady growth…

1 week ago

Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update

– Released positive topline data from Phase 1 study of IV rademikibart in patients with asthma or COPD – –…

1 month ago

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position of $294M, a $44M Increase in 2025 Proposed…

2 months ago

Cellebrite Announces Record Fourth-Quarter and Full-Year 2025 Results

Total ARR grew 21% to $480.8 million; Revenue grew 18% to $128.8 million Net income of $21.3 million supports non-GAAP net…

3 months ago

SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026

February 02, 2026 16:30 ET  | Source: SI-BONE, Inc. SANTA CLARA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc.…

3 months ago

Nokia to publish fourth-quarter and full-year 2025 financial report on 29 January 2026

January 22, 2026 01:00 ET  | Source: Nokia Oyj Press ReleaseNokia to publish fourth-quarter and full-year 2025 financial report on…

3 months ago

Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue

January 13, 2026 07:05 ET  | Source: Treace Medical Concepts, Inc. PONTE VEDRA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) --…

4 months ago

Varonis Announces Date of Fourth Quarter and Full-Year 2025 Financial Results

January 09, 2026 16:05 ET  | Source: Varonis Systems, Inc. MIAMI, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Varonis Systems, Inc.…

4 months ago

Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%

COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to…

9 months ago